Maria Consiglia Bragazzi | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer	CELL REPORTS	2018
A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily	CELL SYSTEMS	2018
Inflammatory and neoplastic cholangiopathies [Colangiopatie infiammatorie e neoplastiche]	RECENTI PROGRESSI IN MEDICINA	2018
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer	CELL REPORTS	2018
A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily	CELL SYSTEMS	2018
lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer	CANCER CELL	2018
A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers	CANCER CELL	2018
Genomic and Functional Approaches to Understanding Cancer Aneuploidy	CANCER CELL	2018
Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas	CANCER CELL	2018
Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation	CELL	2018
The cancerogenic potential of primary human Cholangioracinoma cells is inhibited by Obeticholic Acid, a Farnesoid X Receptor (FXR) agonist	Digestive and Liver Disease	2018
Specific human cholangiocarcinoma (CCA) subpopulations of cancer stem cells (CSCs) express DoubleCortin-Like Kinase 1 (DCLK1) and DCLK1 inhibition induces anti-cancer effects	Digestive and Liver Disease	2018
OC.08.1 DOUBLECORTIN-LIKE KINASE 1 (DCLK1) IS A MARKER OF SPECIFIC SUBPOPULATIONS OF CANCER STEM CELLS (CSCS) IN HUMAN CHOLANGIOCARCINOMA (CCA) AND ITS INHIBITION EXERTS ANTI-CANCER EFFECTS	24th National Congress of Digestive Diseases	2018
Obeticholic acid, a FXR agonist, inhibits the cancerogenic potential of primary human cholangiocarcinoma (CCA) cells cultures	International Liver Congress (ILC) 2018	2018
The FXR Agonist, Obeticholic Acid, Inhibits the Cancerogenic Potential of Primary Human Cholangiocarcinoma Cells: a Study on Primary Human Cell Cultures	24th National Congress of Digestive Diseases	2018
Erratum: Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles (Cell Reports (2017) 18(11) (2780â2794) (S2211124717302140) (10.1016/j.celrep.2017.02.033))	CELL REPORTS	2017
Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis	EGUT	2017
Cholangiocytes: Cell transplantation	BIOCHIMICA ET BIOPHYSICA ACTA. MOLECULAR BASIS OF DISEASE	2017
Metformin reduces cell migration and down-regulates epithelial to mesenchymal transition (EMT) by AMPK/Foxo3a pathway in human intrahepatic cholangiocarcinoma (CCA)	DIGESTIVE AND LIVER DISEASE	2017
Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles	CELL REPORTS	2017